A diet high in α-linolenic acid and monounsaturated fatty acids attenuates hepatic steatosis and alters hepatic phospholipid fatty acid profile in diet-induced obese rats

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 89, Issue 6, 2013, Pages 391-401

  Hanke, Danielle ^a,b   Zahradka, Peter ^a,b   Mohankumar, Suresh K ^a,b   Clark, Jaime L ^a,b   Taylor, Carla G ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

linolenic acid; Diet induced obese rats; Hepatic steatosis; MUFA; N 3 fatty acids

Indexed keywords

CANOLA OIL; DOCOSAHEXAENOIC ACID; FATTY ACID; GLUCOSE; ICOSAPENTAENOIC ACID; LARD; LINOLEIC ACID; LINSEED OIL; LIPID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; PHOSPHOLIPID; SAFFLOWER OIL; SOYBEAN OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY MASS; CALORIC INTAKE; CONTROLLED STUDY; DIET THERAPY; FAT INTAKE; FATTY ACID CHAIN ELONGATION; FATTY ACID DESATURATION; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FATTY LIVER; GLUCOSE METABOLISM; INFLAMMATION; LIPID DIET; LIPID LIVER LEVEL; LIPID METABOLISM; LIVER WEIGHT; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

BRASSICA NAPUS VAR. NAPUS; CARTHAMUS TINCTORIUS; GLYCINE MAX; RATTUS;

(ACC1); (ACOX1); (ALA); (ALT); (AST); (DHA); (DIO); (EPA); (HOMA-IR); (MCP-1); (MUFA); (NAFLD); (PL); (PPAR-Α); (PUFA); (SFA); (SREBP-1C); (TAG); ACETYL-COA CARBOXYLASE 1; ACETYL-COA OXIDASE 1; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; DIET-INDUCED OBESE; DIET-INDUCED OBESE RATS; DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; HEPATIC STEATOSIS; HOMEOSTASIS MODEL ASSESSMENT-INSULIN RESISTANCE; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MONOUNSATURATED FATTY ACIDS; MUFA; N-3 FATTY ACIDS; NON-ALCOHOLIC FATTY LIVER DISEASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR Α; PHOSPHOLIPIDS; POLYUNSATURATED FATTY ACIDS; SATURATED FATTY ACIDS; STEROL REGULATORY ELEMENT-BINDING PROTEIN-1C; TRIACYLGLYCEROLS; Α-LINOLENIC ACID;

ALPHA-LINOLENIC ACID; ANIMALS; DIETARY FATS, UNSATURATED; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; FATTY LIVER; LINSEED OIL; LIPIDS; LIVER; MALE; OBESITY; PHOSPHOLIPIDS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

EID: 84888019126     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2013.09.009     Document Type: Article

References (33)

1. World Health Organization, Obesity and overweight. , 2013 (retrieved 9.07.13). http://www.who.int/mediacentre/factsheets/fs311/en/.
2. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel, Detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III), Final Report, 2002.
3. Marchesini G., Brizi M., Bianchi G., et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50:1844-1850.
4. Williams C.D., Stengel J., Asike M.I., et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011, 140:124-131.
5. Schwimmer J.B., Deutsch R., Kahen T., Lavine J.E., Stanley C., Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006, 118:1388-1393.
6. Araya J., Rodrigo R., Videla L.A., et al. Increase in long-chain polyunsaturated fatty acid n - 6/n - 3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease. Clin. Sci. (Lond) 2004, 106:635-643.
7. Allard J.P., Aghdassi E., Mohammed S., et al. Nutritional assessment and hepatic fatty acid composition in non-alcoholic fatty liver disease (NAFLD): A cross-sectional study. J. Hepatol. 2008, 48:300-307.
8. El-Badry A.M., Graf R., Clavien P.A. Omega 3-omega 6: What is right for the liver?. J. Hepatol. 2007, 47:718-725.
9. Brenna J.T. Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man. Curr. Opin. Clin Nutr. Metab Care 2002, 5:127-132.
10. Sprecher H. Metabolism of highly unsaturated n-3 and n-6 fatty acids. Biochim Biophys. Acta 2000, 1486:219-231.
11. Bjermo H., Riserus U. Role of hepatic desaturases in obesity-related metabolic disorders. Curr. Opin Clin Nutr. Metab Care 2010, 13:703-708.
12. Hunter J.E. N-3 fatty acids from vegetable oils. Am. J. Clin Nutr. 1990, 51:809-814.
13. Reuter T.Y. Diet-induced models for obesity and type 2 diabetes. Drug Discovery Today: Dis. Models 2007, 4:3-8.
14. Lepage L.M., Giesbrecht J.A., Taylor C.G. Expression of T lymphocyte p56(lck), a zinc-finger signal transduction protein, is elevated by dietary zinc deficiency and diet restriction in mice. J. Nutr. 1999, 129:620-627.
15. Noto A., Zahradka P., Yurkova N., et al. Conjugated linoleic acid reduces hepatic steatosis, improves liver function, and favorably modifies lipid metabolism in obese insulin-resistant rats. Lipids 2006, 41:179-188.
16. Noto A., Zahradka P., Ryz N.R., Yurkova N., Xie X., Taylor C.G. Dietary conjugated linoleic acid preserves pancreatic function and reduces inflammatory markers in obese, insulin-resistant rats. Metabolism 2007, 56:142-151.
17. Wang Y., Botolin D., Xu J., et al. Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity. J. Lipid Res. 2006, 47:2028-2041.
18. Mouzaki M., Allard J.P. The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. J. Clin. Gastroenterol. 2012, 46:457-467.
19. Angulo P., Lindor K.D. Non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 2002, 17(Suppl):S186-S190.
20. Neschen S., Moore I., Regittnig W., et al. Contrasting effects of fish oil and safflower oil on hepatic peroxisomal and tissue lipid content. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E395-401.
21. Lombardo Y.B., Chicco A.G. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J. Nutr. Biochem. 2006, 17:1-13.
22. Jump D.B. N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Curr. Opin. Lipidol. 2008, 19:242-247.
23. Buettner R., Parhofer K.G., Woenckhaus M., et al. Defining high-fat-diet rat models: Metabolic and molecular effects of different fat types. J. Mol. Endocrinol. 2006, 36:485-501.
24. Zuliani G., Galvani M., Leitersdorf E., Volpato S., Cavalieri M., Fellin R. The role of polyunsaturated fatty acids (PUFA) in the treatment of dyslipidemias. Curr. Pharm. Des. 2009, 15:4087-4093.
25. Ferrucci L., Cherubini A., Bandinelli S., et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J. Clin. Endocrinol. Metab. 2006, 91:439-446.
26. Stringer D.M., Zahradka P., Declercq V.C., et al. Modulation of lipid droplet size and lipid droplet proteins by trans-10,cis-12 conjugated linoleic acid parallels improvements in hepatic steatosis in obese, insulin-resistant rats. Biochim. Biophys. Acta. 2010, 1801:1375-1385.
27. Buettner R., Scholmerich J., Bollheimer L.C. High-fat diets: Modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 2007, 15:798-808.
28. Nakamura M.T., Nara T.Y. Structure, function, and dietary regulation of delta6, delta5, and delta9 desaturases. Annu. Rev. Nutr. 2004, 24:345-376.
29. Legrand P., Schmitt B., Mourot J., et al. The consumption of food products from linseed-fed animals maintains erythrocyte omega-3 fatty acids in obese humans. Lipids 2010, 45:11-19.
30. Moriguchi T., Lim S.Y., Greiner R., et al. Effects of an n-3-deficient diet on brain, retina, and liver fatty acyl composition in artificially reared rats. J. Lipid Res. 2004, 45:1437-1445.
31. Brenna J.T., Salem N., Sinclair A.J., Cunnane S.C. International Society for the Study of Fatty Acids and Lipids, ISSFAL, Alpha-linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostaglandins Leukot. Essent. Fatty Acids 2009, 80:85-91.
32. Wang Y., Torres-Gonzalez M., Tripathy S., Botolin D., Christian B., Jump D.B. Elevated hepatic fatty acid elongase-5 activity affects multiple pathways controlling hepatic lipid and carbohydrate composition. J. Lipid Res. 2008, 49:1538-1552.
33. Tu W.C., Cook-Johnson R.J., James M.J., Muhlhausler B.S., Gibson R.A. Omega-3 long chain fatty acid synthesis is regulated more by substrate levels than gene expression. Prostaglandins Leukot. Essent. Fatty Acids 2010, 83:61-68.